158 related articles for article (PubMed ID: 18057552)
1. Antidiabetic zinc(II)-N-acetyl-L-cysteine complex: evaluations of in vitro insulinomimetic and in vivo blood glucose-lowering activities.
Adachi Y; Yoshikawa Y; Sakurai H
Biofactors; 2007; 29(4):213-23. PubMed ID: 18057552
[TBL] [Abstract][Full Text] [Related]
2. New insulinomimetic zinc(II) complexes of alpha-amino acids and their derivatives with Zn(N2O2) coordination mode.
Yoshikawa Y; Ueda E; Suzuki Y; Yanagihara N; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2001 May; 49(5):652-4. PubMed ID: 11383627
[TBL] [Abstract][Full Text] [Related]
3. Insulinomimetic zinc(II) complexes with natural products: in vitro evaluation and blood glucose lowering effect in KK-Ay mice with type 2 diabetes mellitus.
Kojima Y; Yoshikawa Y; Ueda E; Ueda R; Yamamoto S; Kumekawa K; Yanagihara N; Sakurai H
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):1006-8. PubMed ID: 12913247
[TBL] [Abstract][Full Text] [Related]
4. A family of insulinomimetic zinc(II) complexes of amino ligands with Zn(Nn) (n=3 and 4) coordination modes.
Yoshikawa Y; Kondo M; Sakurai H; Kojima Y
J Inorg Biochem; 2005 Jul; 99(7):1497-503. PubMed ID: 15921760
[TBL] [Abstract][Full Text] [Related]
5. A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.
Adachi Y; Yoshida J; Kodera Y; Kato A; Yoshikawa Y; Kojima Y; Sakurai H
J Biol Inorg Chem; 2004 Oct; 9(7):885-93. PubMed ID: 15378407
[TBL] [Abstract][Full Text] [Related]
6. A new type of orally active anti-diabetic Zn(II)-dithiocarbamate complex.
Yoshikawa Y; Adachi Y; Sakurai H
Life Sci; 2007 Jan; 80(8):759-66. PubMed ID: 17137606
[TBL] [Abstract][Full Text] [Related]
7. Insulinomimetic bis(maltolato)zinc(II) complex: blood glucose normalizing effect in KK-A(y) mice with type 2 diabetes mellitus.
Yoshikawa Y; Ueda E; Miyake H; Sakurai H; Kojima Y
Biochem Biophys Res Commun; 2001 Mar; 281(5):1190-3. PubMed ID: 11243860
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of Bis(aspirinato)zinc(II) complex ameliorates hyperglycemia and metabolic syndrome-like disorders in spontaneously diabetic KK-A(y) mice: structure-activity relationship on zinc-salicylate complexes.
Yoshikawa Y; Adachi Y; Yasui H; Hattori M; Sakurai H
Chem Pharm Bull (Tokyo); 2011; 59(8):972-7. PubMed ID: 21804241
[TBL] [Abstract][Full Text] [Related]
9. Development of new insulinomimetic zinc(II) picolinate complexes with a Zn(N2O2) coordination mode: structure characterization, in vitro, and in vivo studies.
Yoshikawa Y; Ueda E; Kawabe K; Miyake H; Takino T; Sakurai H; Kojima Y
J Biol Inorg Chem; 2002 Jan; 7(1-2):68-73. PubMed ID: 11862542
[TBL] [Abstract][Full Text] [Related]
10. The pharmacology of the insulinomimetic effect of zinc complexes.
Sakurai H; Adachi Y
Biometals; 2005 Aug; 18(4):319-23. PubMed ID: 16158223
[TBL] [Abstract][Full Text] [Related]
11. Insulinomimetic Zn(II) complexes as evaluated by both glucose-uptake activity and inhibition of free fatty acids release in isolated rat adipocytes.
Nishide M; Yoshikawa Y; Yoshikawa EU; Matsumoto K; Sakurai H; Kajiwara NM
Chem Pharm Bull (Tokyo); 2008 Aug; 56(8):1181-3. PubMed ID: 18670123
[TBL] [Abstract][Full Text] [Related]
12. Antidiabetic activity of perylenequinonoid-rich extract from Shiraia bambusicola in KK-Ay mice with spontaneous type 2 diabetes mellitus.
Huang M; Zhao P; Xiong M; Zhou Q; Zheng S; Ma X; Xu C; Yang J; Yang X; Zhang TC
J Ethnopharmacol; 2016 Sep; 191():71-81. PubMed ID: 27286915
[TBL] [Abstract][Full Text] [Related]
13. Anti-hyperglycemic Effect of Long-Term Bis(hinokitiolato)zinc Complex ([Zn(hkt)
Naito Y; Yoshikawa Y; Shintani M; Kamoshida S; Kajiwara N; Yasui H
Biol Pharm Bull; 2017; 40(3):318-326. PubMed ID: 28250273
[TBL] [Abstract][Full Text] [Related]
14. Blood glucose lowering and toxicological effects of zinc (II) complexes with maltol, threonine, and picolinic acid.
Kojima Y; Yoshikawa Y; Ueda E; Kondo M; Takahashi S; Matsukura T; Sakurai H; Hiroi T; Imaoka S; Funae Y
Res Commun Mol Pathol Pharmacol; 2002; 112(1-4):91-104. PubMed ID: 15080500
[TBL] [Abstract][Full Text] [Related]
15. The action mechanism of zinc(II) complexes with insulinomimetic activity in rat adipocytes.
Yoshikawa Y; Ueda E; Kojima Y; Sakurai H
Life Sci; 2004 Jun; 75(6):741-51. PubMed ID: 15172182
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological and pharmacokinetic studies of anti-diabetic tropolonato-Zn(II) complexes with Zn(S(2)O(2)) coordination mode.
Murakami H; Yasui H; Yoshikawa Y
Chem Pharm Bull (Tokyo); 2012; 60(9):1096-104. PubMed ID: 22976316
[TBL] [Abstract][Full Text] [Related]
17. Structure-dependent metallokinetics of antidiabetic vanadyl-picolinate complexes in rats: studies on solution structure, insulinomimetic activity, and metallokinetics.
Yasui H; Tamura A; Takino T; Sakurai H
J Inorg Biochem; 2002 Jul; 91(1):327-38. PubMed ID: 12121792
[TBL] [Abstract][Full Text] [Related]
18. Potential insulinominetic agents of zinc(II) complexes with picolinamide derivatives: preparations of complexes, in vitro and in vivo studies.
Ueda E; Yoshikawa Y; Ishino Y; Sakurai H; Kojima Y
Chem Pharm Bull (Tokyo); 2002 Mar; 50(3):337-40. PubMed ID: 11911195
[TBL] [Abstract][Full Text] [Related]
19. Antidiabetic effects of flavonoids from Sophora flavescens EtOAc extract in type 2 diabetic KK-ay mice.
Yang X; Yang J; Xu C; Huang M; Zhou Q; Lv J; Ma X; Ke C; Ye Y; Shu G; Zhao P
J Ethnopharmacol; 2015 Aug; 171():161-70. PubMed ID: 26051831
[TBL] [Abstract][Full Text] [Related]
20. Syntheses of vanadyl and zinc(II) complexes of 1-hydroxy-4,5,6-substituted 2(1H)-pyrimidinones and their insulin-mimetic activities.
Yamaguchi M; Wakasugi K; Saito R; Adachi Y; Yoshikawa Y; Sakurai H; Katoh A
J Inorg Biochem; 2006 Feb; 100(2):260-9. PubMed ID: 16387366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]